Svenska
Boston
An independent LDT provider
Home
About us
Home
About us
Learn more
Vision and mission
Leadership
About us
Leadership
Learn more
Board of directors
Management team
Medical Advisory Board
Collaborations
About us
Collaborations
Learn more
Patient Advocacy Support
Immunovia, Inc.
Immunovia Dx Laboratory, Lund
Company history
Sustainability
About us
Sustainability
Learn more
Sustainability report
Code of conduct
Work environment
Diversity
Calendar
Careers
IMMray™ Platform
Home
IMMray™ Platform
Learn more
Technology
Production
Pancreatic Cancer
IMMray™ Platform
Pancreatic Cancer
Learn more
Pancreatic cancer high risk groups
Clinical performance
Clinical prospective study program
Current technologies for detection and diagnosis
Investors
Media
Home
Media
Learn more
Press releases
Presentations
Webinars
Tutorials
Videos
Audio
Publications
Social media
Media resources
Partnering
Contact Us
Subscribe
Immunovia Inc
English
Svenska
NOTE:
Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here:
https://rb.gy/09bxx
Immunovia CEO Patrik Dahlen presents the company at Vator Securities Healthcare Innovation Summit
October 12, 2021
Home
Immunovia CEO Patrik Dahlen presents the company at Vator Securities Healthcare Innovation Summit
